Kenvue stock forecast
Kenvue's weighted case is $22.14 by October 2027 and $24.12 by October 2029, with a 55% base case. It hinges on sustained volume and share recovery, especially in Skin Health and Beauty, and whether cash generation supports dividends and debt needs.
Where could Kenvue's shares be by October 2029?
The weighted case is $22.14 by October 2027, a 22% return including dividends, and $24.12 by October 2029, a 41% return including dividends. The bear case carries 25% probability. The base case carries 55%, and the bull case 20%.
The weighted price reaches $22.14 in October 2027, a 22% return including dividends. It reaches $23.13 in October 2028, a 31% return. By October 2029, it reaches $24.12, or 41% including dividends.
| Case | Probability | October 2027 | October 2028 | October 2029 |
|---|---|---|---|---|
| Bear | 25 % | 14.98 (-16 %) | 13.45 (-22 %) | 12.80 (-23 %) |
| Base | 55 % | 22.50 (+23 %) | 23.22 (+32 %) | 23.95 (+41 %) |
| Bull | 20 % | 30.10 (+64 %) | 35.00 (+94 %) | 38.76 (+120 %) |
| Weighted | 100 % | 22.14 (+22 %) | 23.13 (+31 %) | 24.12 (+41 %) |
What has to go right, and what could go wrong for Kenvue?
The bear case gives $1,800 million initially, then $1,850 million and $1,900 million because weak volume and margin pressure persist. The bull case gives $2,750 million, $2,920 million and $3,100 million because Skin Health and Beauty gains broaden, Self Care stabilizes and the restructuring works. The $200 million savings target supports improvement, but it is gross savings, not earnings.
How much cash does Kenvue really make?
Stock compensation is another shareholder cost. Kenvue keeps the cash, but employees receive shares or share-based awards, leaving existing owners with a smaller claim unless Kenvue repurchases shares. The analytical “real free cash flow” subtracts that cost. Restructuring payments are already inside operating cash flow, so subtracting them again would double count them.
| 2025 | 2024 | 2023 | Jan 2023 | Jan 2022 | |
|---|---|---|---|---|---|
| Cash from operations | 2,197 | 1,769 | 3,168 | 2,525 | 334 |
| − Capital spending | 475 | 434 | 469 | 375 | 295 |
| = Free cash flow | 1,722 | 1,335 | 2,699 | 2,150 | 39 |
| − Stock pay | 136 | 254 | 188 | 137 | 141 |
| = Real free cash flow | 1,586 | 1,081 | 2,511 | 2,013 | -102 |
| Real free cash flow, % of revenue | 10.5% | 7.0% | 16.3% | 13.5% | -0.7% |
What this means. The company's own free cash flow is slightly different from ours because it rounds the figures and sometimes subtracts small items that we do not.
What does Kenvue's stock price pay for in earnings and cash?
The price-to-earnings ratio, or P/E, compares the share price with earnings. Its trailing version uses the last twelve months; its forward version uses the next twelve months. The other measures in the table compare business value with revenue, share price with accounting equity, and annual cash generation with the equity price. Book value is an imperfect guide for a branded company because accounting does not fully capture customer habits and trusted names.
| Today (Oct 19, 2026) | |
|---|---|
| Share price | 18.905 |
| Market value (calculated) | 36,312.22 |
| Enterprise value (calculated) | 43,682.22 |
| P/E, last 12 months (calculated) | 21.7x |
| P/E, next 12 months (calculated) | 15.2x |
| Real free cash flow yield (calculated) | 4.4% |
What this means. The next-year price-to-earnings number uses analysts’ guesses about future profit, so it may be wrong.